Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

MORNING BID-Still too hot

BY Reuters
— 2:54 AM ET 05/12/2022

A look at the day ahead from Danilo Masoni. The return of U.S. inflation to more bearable levels is not going to happen overnight so those who were hoping for a clear signal that price pressures had peaked got disappointed.

April's hot consumer price data did leave bets of aggressive Fed tightening broadly intact and with them the spectre that a hard landing for the world's top economy may become unavoidable.

The fall of the headline figure to below the 40-year peak did provide some comfort, helping world stocks, already flirting with bear market territory, regain some footing after an initial kneejerk plunge. But that bounce was short-lived.

The Nasdaq fell over 3%, logging its worst five-day drop since March 2020. Asian shares absorbed the pain with a 2.5% drop to almost 2-year lows and European equity index futures are pointing to an ugly day ahead.

The risk of a recession also reversed the spike in Treasury yields which now look set to fall further this morning while the only winner appears to be the dollar which has rocketed to a new 20-year peak. A Wall Street fear gauge is above 30 for a fifth consecutive day.

Meantime, finance ministers and central bank governors from Japan, China and South Korea warned of risks to Asia's economic recovery from the COVID-19 pandemic and from early interest rate rises "in some advanced nations".

Oil too is down. Cryptocurrency markets are in meltdown mode with so-called stablecoin TerraUSD collapsing and Bitcoin falling below $27,000 to give up its 2021 gains.

Positive soundings from the earnings season in Europe may do little to save the day. Analysts now see profit growth north of 40%, up from around 20% forecast two months ago, per Refinitiv I/B/E/S data.

Key developments that should provide more direction to markets on Thursday:

- Britain's economy shrank by 0.1% in March but expanded by 0.8% in Q1 in what is likely to have been a high point for 2022 as the cost of living crisis increasingly bites

- San Francisco Fed President Mary Daly

- U.S. President Joe Biden will host leaders of the Association of Southeast Asian Nations (ASEAN) at a summit in Washington (to May 13)

- G7 Foreign Minister meeting

- Final U.S. PPI/initial jobless claims

- U.S. Treasury 30-year bond auction

- U.S. earnings: Alibaba (BABA), Motorola

- European earnings: Aegon, Allianz, BT, KBC Groep, Merck (MRK), Prysmian, Prosiebensat, RWE, Siemens

(Reporting by Danilo Masoni; Editing by Saikat Chatterjee)

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

More MRK News

  • New class of cancer drugs down, not out, after Roche trial setback - analysts
    Reuters - 2:00 AM ET 05/12/2022
  • New class of cancer drugs down, not out, after Roche trial setback - analysts
    Reuters - 2:28 PM ET 05/11/2022
  • 15 Stocks Moved By Traders on 'Fast Money: Halftime Report'
    Benzinga - 1:52 PM ET 05/11/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close